Search research articles
Contact Us
Filters
Showing results (211-220 of 261) with videos related to
Page
of 27
Sort By:
American Journal of Medical Genetics. Part A
|
June 20, 2012
Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome
Kana Hosoki, Tohru Ohta, Jun Natsume, et al.
Scientific Reports
|
February 8, 2024
Mogrol stimulates G-protein-coupled bile acid receptor 1 (GPBAR1/TGR5) and insulin secretion from pancreatic β-cells and alleviates hyperglycemia in mice
Chisato Tanaka, Naoki Harada, Yoshiaki Teraoka, et al.
Journal of Human Genetics
|
April 20, 2006
Microarray comparative genomic hybridization (CGH)-based prenatal diagnosis for chromosome abnormalities using cell-free fetal DNA in amniotic fluid
Shoko Miura, Kiyonori Miura, Hideaki Masuzaki, et al.
American Journal of Medical Genetics
|
September 5, 2002
Duplication of 8p23.2: a benign cytogenetic variant?
Naoki Harada, Jun Takano, Tatsuro Kondoh, et al.
International Journal of Hematology
|
January 17, 2009
Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
Katsuto Takenaka, Tetsuya Eto, Koji Nagafuji, et al.
European Journal of Haematology
|
June 30, 2007
Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation
Yasuo Mori, Goichi Yoshimoto, Takashi Kumano, et al.
International Journal of Hematology
|
November 14, 2008
Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9
Takatoshi Aoki, Toshihiro Miyamoto, Shuro Yoshida, et al.
Annals of Hematology
|
February 24, 2015
Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics
Satoshi Yamasaki, Goichi Yoshimoto, Ryosuke Ogawa, et al.
Experimental Hematology
|
May 18, 2016
Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis
Shinya Daitoku, Katsuto Takenaka, Takuji Yamauchi, et al.
Journal of Pediatric Hematology/Oncology
|
June 24, 2006
Congenital neuroblastoma in a patient with partial trisomy of 2p
Yuri Dowa, Toshiyuki Yamamoto, Yasuko Abe, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 261) with videos related to
Sort By:
Page
of 27
American Journal of Medical Genetics. Part A
|
June 20, 2012
Clinical phenotype and candidate genes for the 5q31.3 microdeletion syndrome
Kana Hosoki, Tohru Ohta, Jun Natsume, et al.
Scientific Reports
|
February 8, 2024
Mogrol stimulates G-protein-coupled bile acid receptor 1 (GPBAR1/TGR5) and insulin secretion from pancreatic β-cells and alleviates hyperglycemia in mice
Chisato Tanaka, Naoki Harada, Yoshiaki Teraoka, et al.
Journal of Human Genetics
|
April 20, 2006
Microarray comparative genomic hybridization (CGH)-based prenatal diagnosis for chromosome abnormalities using cell-free fetal DNA in amniotic fluid
Shoko Miura, Kiyonori Miura, Hideaki Masuzaki, et al.
American Journal of Medical Genetics
|
September 5, 2002
Duplication of 8p23.2: a benign cytogenetic variant?
Naoki Harada, Jun Takano, Tatsuro Kondoh, et al.
International Journal of Hematology
|
January 17, 2009
Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
Katsuto Takenaka, Tetsuya Eto, Koji Nagafuji, et al.
European Journal of Haematology
|
June 30, 2007
Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation
Yasuo Mori, Goichi Yoshimoto, Takashi Kumano, et al.
International Journal of Hematology
|
November 14, 2008
Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9
Takatoshi Aoki, Toshihiro Miyamoto, Shuro Yoshida, et al.
Annals of Hematology
|
February 24, 2015
Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics
Satoshi Yamasaki, Goichi Yoshimoto, Ryosuke Ogawa, et al.
Experimental Hematology
|
May 18, 2016
Calreticulin mutation does not contribute to disease progression in essential thrombocythemia by inhibiting phagocytosis
Shinya Daitoku, Katsuto Takenaka, Takuji Yamauchi, et al.
Journal of Pediatric Hematology/Oncology
|
June 24, 2006
Congenital neuroblastoma in a patient with partial trisomy of 2p
Yuri Dowa, Toshiyuki Yamamoto, Yasuko Abe, et al.
Page
of 27